BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7838536)

  • 1. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
    Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
    Harhaj E; Blaney J; Millhouse S; Sun SC
    Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
    Lisziewicz J; Rappaport J; Dhar R
    New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
    Taylor JP; Kundu M; Khalili K
    Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
    Shatrov VA; Boelaert JR; Chouaib S; Dröge W; Lehmann V
    Eur Cytokine Netw; 1997 Mar; 8(1):37-43. PubMed ID: 9110146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
    Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K
    J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
    Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
    J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling Tat.
    Karn J
    J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tat mediates transcriptional activation of HIV-1 gene in vitro.
    West M; Hoover T; Kung H; Raziuddin
    Indian J Biochem Biophys; 1995 Dec; 32(6):351-5. PubMed ID: 8714203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B.
    Laughlin MA; Chang GY; Oakes JW; Gonzalez-Scarano F; Pomerantz RJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):332-9. PubMed ID: 7600100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.